CRISPR: The new, highly programmable technology shaking up Covid-19 testing

As chief technology officer at Sherlock, Will Blake was part of the team that gained the first ever FDA approval for a CRISRP-based diagnostic kit (Credit: Sherlock Biosciences)



Related Article
Recommended Whitepaper

View More